Today's top story

Market outlook for biosimilars: how streamlining will enable growth

One of the central themes emerging from this year’s World Biosimilar Congress held in Basel was that biosimilar manufacturers will become more strategic about the markets they target for launching new products in the months and years ahead. This is necessary if the overall market is to grow and remain profitable.

Generics and Biosimilars

Tailor your content

Most Read

About Out-Law

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.